We are live on ! Find out more
NICM

Neo Ivy Capital Management Portfolio holdings

AUM $379M
1-Year Est. Return 28.34%
This Fund
S&P 500
This Quarter Est. Return
+18.75%
1 Year Est. Return
+28.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$87.2M
AUM Growth
+$25.8M
Cap. Flow
+$18.4M
Cap. Flow %
21.14%
Top 10 Hldgs %
9.07%
Holding
666
New
217
Increased
117
Reduced
105
Closed
226

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$883K
2
LHX icon
L3Harris
LHX
+$877K
3
JNJ icon
Johnson & Johnson
JNJ
+$836K
4
INTC icon
Intel
INTC
+$803K
5
PRU icon
Prudential Financial
PRU
+$759K

Top Sells

Rank Stock Value
1
ETR icon
Entergy
ETR
+$563K
2
COST icon
Costco
COST
+$557K
3
CTAS icon
Cintas
CTAS
+$506K
4
TMO icon
Thermo Fisher Scientific
TMO
+$503K
5
ALK icon
Alaska Air
ALK
+$476K

Sector Composition

Rank Sector Weight
1 Technology 17.61%
2 Financials 17.3%
3 Industrials 15.25%
4 Healthcare 15.11%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUN icon
401
Huntsman Corp
HUN
$1.83B
$15K 0.02%
850
-2,443
-74% -$41K
INO icon
402
Inovio Pharmaceuticals
INO
$79.1M
$15K 0.02%
+45
New +$7.23K
SFIX
403
Stitch Fix
SFIX
$499M
$15K 0.02%
+615
New +$12.1K
TOL icon
404
Toll Brothers
TOL
$14.3B
$15K 0.02%
+448
New +$12.3K
XPO icon
405
XPO
XPO
$23.8B
$15K 0.02%
561
-10,152
-95% -$243K
IMMU
406
DELISTED
Immunomedics Inc
IMMU
$15K 0.02%
430
-379
-47% -$11.1K
AXP icon
407
American Express
AXP
$230B
$14K 0.02%
+146
New +$13.4K
SABR icon
408
Sabre
SABR
$803M
$14K 0.02%
+1,745
New +$12.4K
TNDM icon
409
Tandem Diabetes Care
TNDM
$1.63B
$14K 0.02%
+142
New +$11.3K
PRMW
410
DELISTED
Primo Water Corporation
PRMW
$14K 0.02%
+1,032
New +$11.6K
INSM icon
411
Insmed
INSM
$29B
$13K 0.01%
+456
New +$10.8K
WU icon
412
Western Union
WU
$2.2B
$13K 0.01%
584
-20,545
-97% -$417K
DFS
413
DELISTED
Discover Financial Services
DFS
$12K 0.01%
+238
New +$10.5K
BLDR icon
414
Builders FirstSource
BLDR
$8.08B
$11K 0.01%
+526
New +$9.5K
WGO icon
415
Winnebago Industries
WGO
$927M
$10K 0.01%
+157
New +$8.02K
AL
416
DELISTED
Air Lease Corp
AL
$9K 0.01%
+311
New +$8.3K
EBS icon
417
Emergent Biosolutions
EBS
$228M
$9K 0.01%
117
-442
-79% -$32.9K
CADE
418
DELISTED
Cadence Bank
CADE
$8K 0.01%
369
-4,301
-92% -$91.2K
LKQ icon
419
LKQ Corp
LKQ
$6.25B
$8K 0.01%
+300
New +$7.38K
MTSI icon
420
MACOM Technology Solutions
MTSI
$22.9B
$8K 0.01%
+227
New +$6.63K
WPX
421
DELISTED
WPX Energy, Inc.
WPX
$8K 0.01%
+1,283
New +$7.24K
KLAC icon
422
KLA
KLAC
$262B
$7K 0.01%
380
-710
-65% -$12.1K
SPR
423
DELISTED
Spirit AeroSystems
SPR
$7K 0.01%
291
-2,101
-88% -$47.6K
STT icon
424
State Street
STT
$51.4B
$7K 0.01%
109
-517
-83% -$31.2K
HAL icon
425
Halliburton
HAL
$28.2B
$6K 0.01%
+489
New +$5.27K

Similar funds

Neo Ivy Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Neo Ivy Capital Management held 666 positions worth $87.2M, up 42% from $61.4M the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Neo Ivy Capital Management deployed $18.4M of net new capital in Q2 2020, opening 217 new positions and adding to 117 existing holdings. Its largest new stake was Pfizer: 26,000 shares worth $807K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Cintas, an estimated $506K trimmed.

  • Neo Ivy Capital Management's largest Q2 2020 buy was Pfizer: 26,000 shares worth $807K.
  • Neo Ivy Capital Management added most to CME Group in Q2 2020, an estimated $750K increase.
  • Neo Ivy Capital Management's biggest Q2 2020 reduction was Cintas, cutting an estimated $506K.
  • Neo Ivy Capital Management fully exited Entergy in Q2 2020, selling an estimated $563K.
  • Neo Ivy Capital Management's ten largest holdings make up 9.1% of its $87.2M portfolio in Q2 2020.
  • Neo Ivy Capital Management opened 217 new positions and closed 226 in Q2 2020.
  • Neo Ivy Capital Management's portfolio value rose 42% quarter-over-quarter to $87.2M.

Based on Neo Ivy Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.